CD38 and Miyoshi myopathy: In another example, XmAb13551, which is a CD38 × CD3 BsAb (8 nM affinity for human CD3) against multiple myeloma (MM), showed effective MM cell clearance in mice [70] but triggered CRS at doses >0.2 mg/kg in monkeys [71].